Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel liquid-phase synthesis method for high-purity kappa opioid agonist intermediates, offering significant cost and purity advantages over solid-phase methods.
Novel green synthesis of Dapoxetine from acetophenone. Improved yield, reduced waste, scalable industrial process for pharmaceutical intermediates.
Patent CN111362807B details a green aerobic oxidation route for 3-nitro-2-methylbenzoic acid, offering high purity and reduced waste for pharmaceutical supply chains.
Novel radical coupling method for heterocyclic sulfones. Reduces corrosive reagents, enhances supply chain reliability for pharmaceutical intermediate manufacturing.
Novel room-temperature synthesis of 2-aminopyridine derivatives offers high yields and cost reduction in pharmaceutical intermediate manufacturing for reliable supply chains.
Novel patent CN104557975A offers efficient everolimus intermediate synthesis. Reduces impurities, ensures supply chain stability for pharmaceutical manufacturing.
Novel nitrite substitution method enhances safety and reduces cost for silodosin intermediate manufacturing supply chain reliability and purity.
Novel rhodium-catalyzed route for high-purity 7-azaindole derivatives. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Patent CN106518939A reveals a cost-effective Solithromycin route avoiding azides. Enhances supply chain reliability and purity for pharmaceutical intermediates.
Patent CN102086165A reveals a novel Pd-catalyzed hydrogenation route for doxycycline intermediates, offering superior stereoselectivity and reduced environmental impact for pharmaceutical manufacturing.
Novel visible-light method for amino acids. Reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN116396201A details a safe, scalable DeoxoFluor route for (2R,4R)-4-fluoropyrrolidine-2-carboxylic acid, offering significant cost and safety advantages over traditional DAST methods.
Advanced synthetic route for Ticagrelor intermediate avoiding nitration. Enhanced safety, reduced waste, and scalable manufacturing for global pharmaceutical supply chains.
Patent CN111440147B details a convergent route for Imatinib intermediates with high purity and mild conditions, offering reliable supply chain solutions.
Novel one-step synthesis patent CN103319335B offers high purity greater than 99 percent. Reduces equipment investment and enables green manufacturing for pharmaceutical intermediates.
Patent CN114671849B discloses a mild ring-opening method for glucopyranosides, offering high yields and environmental benefits for reliable pharmaceutical intermediate suppliers.
Novel Rh-catalyzed synthesis of tetrahydroisoquinoline derivatives offers high yields and mild conditions for anticancer drug development.
Patent CN107266392A reveals a base-free aqueous synthesis for sulfamates offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Advanced manufacturing of (S)-4-isobutyl-dihydro-3H-furan-2-one via a novel Grignard route. Offers significant cost reduction and scalable production for pharmaceutical intermediates.
Patent CN110143861B reveals heavy-metal-free ibuprofen synthesis. Achieve cost reduction and supply chain stability with high-purity manufacturing capabilities.